Helen Rizos
Macquarie University
H-index: 60
Oceania-Australia
Top articles of Helen Rizos
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Checkpoint kinase 1 inhibitor+ low‐dose hydroxyurea efficiently kills BRAF inhibitor‐and immune checkpoint inhibitor‐resistant melanomas | Pigment Cell & Melanoma Research | Zhen Zeng Hung Long Ngo Martina Proctor Helen Rizos Riccardo Dolcetti | 2024/1 |
Neoadjuvant Triplet Immune Checkpoint Blockade in Newly Diagnosed Glioblastoma | Georgina Long James Wilmott Elena Shklovskaya Laveniya Satgunseelan Yizhe Mao | 2024/4/29 | |
Ex vivo tissue modelling informs drug selection for rare cancers | International Journal of Cancer | Jenny H Lee Zizhen Ming Veronica KY Cheung Bernadette Pedersen James J Wykes | 2024/4/1 |
PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma | Oncogenesis | John J Park Sabine Abou Hamad Ashleigh Stewart Matteo S Carlino Su Yin Lim | 2024/2/28 |
Single-cell RNA sequencing in melanoma: what have we learned so far? | Su Yin Lim Helen Rizos | 2024/2/1 | |
Single cell profiling of tumour biopsies and heterogeneity in response of dedifferentiated melanoma. | Esther Lim Yingxin Lin Bernadette Pedersen Ashleigh Stewart Richard A Scolyer | 2023/8 | |
Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA … | Clinical Cancer Research | Hansol Lee Angela L Ferguson Camelia Quek Ismael A Vergara Ines Pires daSilva | 2023/7/5 |
IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics | Journal of Investigative Dermatology | Zizhen Ming Su Yin Lim Ashleigh Stewart Bernadette Pedersen Elena Shklovskaya | 2023/7/1 |
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma | Nature Communications | Su Yin Lim Elena Shklovskaya Jenny H Lee Bernadette Pedersen Ashleigh Stewart | 2023/3/18 |
Helen Rizos | Helen Rizos | 2023/1/13 | |
SERS characterization of colorectal cancer cell surface markers upon anti‐EGFR treatment | Exploration | Nana Lyu Bernadette Pedersen Elena Shklovskaya Helen Rizos Mark P Molloy | 2022/6 |
Overcoming resistance to immunotherapy with BH3 mimetics | Z Ming A Stewart B Pedersen E Lim AM Menzies | 2022 | |
Durable responses to anti-Pd1 and anti-Ctla4 in a Preclinical model of Melanoma displaying key Immunotherapy response biomarkers | Cancers | Elena Shklovskaya Bernadette Pedersen Ashleigh Stewart Jack OG Simpson Zizhen Ming | 2022/10/3 |
Repurposing melanoma chemotherapy to activate inflammasomes in the treatment of BRAF/MAPK inhibitor resistant melanoma | Journal of Investigative Dermatology | Farzana Ahmed Hsin-Yi Tseng Antonio Ahn Dilini Gunatilake Sara Alavi | 2022/5/1 |
Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling | Cancer Gene Therapy | John J Park Ashleigh Stewart Mal Irvine Bernadette Pedersen Zizhen Ming | 2022/10 |
Anchored multiplex PCR custom melanoma next generation sequencing panel for analysis of circulating tumor DNA | Frontiers in Oncology | Russell J Diefenbach Jenny H Lee Ashleigh Stewart Alexander M Menzies Matteo S Carlino | 2022/4/12 |
Comprehensive clinical, histopathologic, and molecular analysis and long-term follow-up of patients with nodal blue nevi | The American Journal of Surgical Pathology | Andrew J Colebatch Chandra Adhikari Russell J Diefenbach Robert V Rawson Peter M Ferguson | 2022/8/1 |
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance | Cancer cell | Felicity Newell Ines Pires da Silva Peter A Johansson Alexander M Menzies James S Wilmott | 2022/1/10 |
Protein‐based classification of melanoma differentiation subtypes. | Pigment Cell & Melanoma Research | Su Yin Lim Bernadette Pedersen Helen Rizos | 2022/7/1 |
Molecular and functional landscape of immune checkpoint resistance in melanoma | E Lim J Lee B Pedersen A Stewart Z Ming | 2022 |
Co-Authors
